As part of our series of white papers tracking clinical trials activity across the world, GlobalData recently compiled a summary of the clinical trials initiated in Japan.
26 September 2017
17 August 2017
Glytec has received its fourth clearance from the US Food and Drug Administration (FDA) for its diabetes therapy management software, Glucommander.
15 August 2017
US-based Tandem Diabetes Care has started patient enrolment for the PROLOG clinical trial of its t:slim X2 Insulin Pump featuring predictive low glucose suspend (PLGS) technology.
16 July 2017
Abbott has signed an agreement to integrate its FreeStyle Libre glucose sensing technology with Bigfoot Biomedical’s insulin delivery solutions to develop and commercialise diabetes management systems in the US.
11 July 2017
French firm Defymed has developed a new insulin delivery device ExOlin to facilitate better disease management for both type 1 and type 2 diabetes patients.
3 July 2017
Roche has purchased all shares of Austria-based mobile diabetes platform mySugr, strengthening its digital health services for diabetes care.
11 June 2017
Switzerland-based Ascensia Diabetes Care has entered a global technology partnership with French firm Voluntis to optimise insulin management for patients suffering from type 2 diabetes.
8 May 2017
A new American Cancer Society study revealed that as sugary beverages have become more affordable around the world, global sugar consumption has climbed.
19 February 2017
Insulet, a medical device company, has reported positive results from the first feasibility study of its Omnipod Horizon hybrid closed-loop system for the treatment of patients with type 1 diabetes.
9 February 2017
Medical devices firm EnteroMedics has published positive three-year data from its VBLOC DM2 study of vBloc neurometabolic therapy in obese patients with Type 2 diabetes, in the Journal of Diabetes...